{"page_content": "About           +           Serve           +           Transform           +           Advance           +           Redefine           +           Ethics & Compliance                      Reporting Index           \nBRIGHTER FUTURES  |  2019 CSR Report58\nDISCLOSURE TITLE EXPLANATION or LOCATION\n102-45Entities included in the consolidated \nfinancial statements Alexion 2019 Form 10-K, Exhibit 21.1 (Subsidiaries of Alexion Pharmaceuticals, Inc.)\n102-46Defining report content and topic Boundaries Alexion 2019 CSR Report, About Alexion: Working Toward Brighter Futures for All of Our \nStakeholders, Page 14 (About This Report) \n102-47 List of material topics Alexion 2019 CSR Report, About Alexion: Working Toward Brighter Futures for All of Our Stakeholders, Page 14 (Material (CSR) Topics) \n102-48 Restatements of information N/A - This is Alexion\u2019s first CSR Report\n102-49 Changes in reporting N/A - This is Alexion\u2019s first CSR Report\n102-50 Reporting period Calendar year 2019, which also serves as Alexion\u2019s fiscal year.\n102-51 Date of most recent report This report \n102-52 Reporting cycle Alexion reports on an annual basis. \n102-53Contact point for questions \nregarding the report CSR@alexion.com\n102-54Claims of reporting in accordance with the GRI StandardsThis report references disclosures from the GRI Standards 2018 and the SASB Biotechnology & Pharmaceuticals Industry, as detailed in this index.\n102-55 GRI content index\nAlexion 2019 CSR Report, Reporting Index, Pages 52-65\nTopic-specific Disclosures: Economic\nECONOMIC PERFORMANCE\n201-1Direct economic value generated \nand distributedAlexion 2019 Form 10-K, Item 8 (Financial Statements and Supplementary Data)\nAlexion 2019 CSR Report, About Alexion: Working Toward Brighter Futures for All of Our \nStakeholders, Page 8 (Company Snapshot)", "metadata": {"source": "NASDAQ_ALXN_2019.pdf", "page": 57, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}